Last reviewed · How we verify
NCT06365775
Multi-omics Characteristics and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
trial in Sudden Sensorineural Hearing Loss in 400 participants. Not yet recruiting.
23 November 2026
Quick facts
| Lead sponsor | Dan Bing |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 23 April 2024 |
| Primary completion | 23 November 2026 |
| Estimated completion | 23 November 2026 |
Conditions studied
- Sudden Sensorineural Hearing Loss — all drugs for Sudden Sensorineural Hearing Loss →
- Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →
- Hearing Loss, Sudden — all drugs for Hearing Loss, Sudden →
Sponsor
Dan Bing
Who can join
Adults 4 to 65, any sex, with Sudden Sensorineural Hearing Loss or Hearing Loss, Sensorineural. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to describe the multi-omics characteristics and to learn about the prognostic factors in patients with idiopathic sudden sensorineural hearing loss (SSNHL). The main problems it aims to deal with are: * if there is a difference in data of exome and targeted sequencing among patients with SSNHL affecting bilateral and unilateral sides, and healthy controls * if there is a difference in the parameter of MRI among patients with SSNHL affecting bilateral and unilateral sides, and healthy controls * to find out which factor from multi-omics data relates to outcomes of SSNHL * to develop the best prognostics model based on the multi-omics data. Participants will be received audiological tests, blood specimen collection and radiological examination. Researchers will explore the relationship between the multi-omics data and the prognosis and develop the predictive model.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06365775
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sudden Sensorineural Hearing Loss
Currently open trials in the same condition.
- NCT06968507 — Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Se · Phase 4 · recruiting
- NCT06249919 — A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients · Phase 1, PHASE2 · recruiting
- NCT04826237 — Oral Statins and Protection From Hearing Loss · Phase 4 · recruiting
Other Dan Bing trials
Trials by the same sponsor.
- NCT07515482 — Effect of Manual Acupuncture on Acute Primary Tinnitus: A Multicenter Randomized Controlled Clinical Trial · NA · not yet recruiting
- NCT06365749 — Genetic Feature of Congenital Hearing Loss in Chinese Population · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06365775 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dan Bing
- Last refreshed: 15 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06365775.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing